Health and disease data collection in Northern Sweden
Northern Sweden Health and Disease Study
This study is collecting blood samples and health information from people in Northern Sweden to see how it can help understand and improve the diagnosis of various diseases like heart problems, cancer, and respiratory issues.
Quick facts
| Study type | Observational |
|---|---|
| Enrollment | 120000 (estimated) |
| Sex | All |
| Sponsor | Umeå University Academic / other |
| Locations | 1 site (Umeå, Västerbotten) |
| Trial ID | NCT03426488 on ClinicalTrials.gov |
What this trial studies
The Northern Sweden Health and Disease Study (NSHDS) is a prospective biobank initiative that collects blood samples and survey data to support research on various health conditions, including cardiovascular diseases, cancer, neurodegenerative diseases, and respiratory diseases. It includes three subcohorts, with a focus on improving diagnostic tools and identifying early disease markers. Participants, primarily from the Västerbotten region, are invited to complete health questionnaires and donate blood samples, which are stored for future research and linked to national health registries for comprehensive outcome tracking.
Who should consider this trial
Good fit: Ideal candidates for this study are residents of Northern Sweden, particularly those aged 40, 50, and 60.
Not a fit: Patients outside of Northern Sweden or those not within the specified age range may not benefit from this study.
Why it matters
Potential benefit: If successful, this study could lead to improved diagnostic tools and early detection methods for serious health conditions.
How similar studies have performed: Other studies utilizing biobanks and health registries have shown success in identifying disease markers and improving health outcomes.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * Residents in Northern Sweden Exclusion Criteria: * None
Where this trial is running
Umeå, Västerbotten
- Umeå University — Umeå, Västerbotten, Sweden (Recruiting)
Study contacts
- Principal investigator: Göran Hallmans, MD PhD — Umeå University
- Study coordinator: Göran Hallmans, MD, PhD
- Email: goran.hallmans@umu.se
- Phone: +46706382516
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.